Clinical Trials Logo

Coronary Artery Disease clinical trials

View clinical trials related to Coronary Artery Disease.

Filter by:

NCT ID: NCT00759811 Completed - Heart Failure Clinical Trials

METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure (METIS Trial)

METIS
Start date: December 2007
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of the study is to evaluate the efficacy of methotrexate to improve physical capacity in patients with symptomatic ischemic heart failure.

NCT ID: NCT00758654 Completed - Clinical trials for Coronary Artery Disease

Strain-Encoded Cardiac Magnetic Resonance Imaging for Dobutamine Stress Testing

Start date: January 2007
Phase: N/A
Study type: Observational

The purpose of this study is to compare the diagnostic value of SENC to that provided by conventional wall motion analysis for the detection of inducible ischemia during DS-MRI.High-dose dobutamine stress magnetic resonance imaging (DS-MRI) is safe and feasible for the diagnosis of coronary artery disease (CAD) in humans. However, the assessment of cine scans relies on the visual interpretation of regional wall motion, which is subjective. Recently, Strain-Encoded MRI (SENC) has been proposed for the direct color-coded visualization of myocardial strain.

NCT ID: NCT00756379 Active, not recruiting - Clinical trials for Coronary Artery Disease

Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease

Century
Start date: March 11, 2009
Phase: N/A
Study type: Interventional

The Century Trial is a single center Phase III randomized study sponsored by the Albert Weatherhead III Foundation and conducted by Dr. K. Lance Gould. The study hypothesis is that a combined image-treatment regimen of PET + comprehensive program of lifestyle modification and lipid lowering drugs to target lipid level will result in an improved cardiovascular risk score when compared to current standard optimal medical therapy, potentially resulting in a lower rate of death, non-fatal myocardial infarction (MI) and revascularization procedures during long term follow-up when compared with current standard of care. If our hypothesis is correct, we will not only improve our ability to prevent and treat CAD but we will also illustrate that, even with the expenses of behavioral interventions and imaging techniques, we can be very cost effective. This information may help patients at risk or with known CAD to obtain insurance coverage to prevent the disease as well as providing a more effective way of treating it.

NCT ID: NCT00756236 Active, not recruiting - Myocardial Ischemia Clinical Trials

A Comparison of the Effects of Intraoperative Administration of Metoprolol or Esmolol on General Anesthetic Requirement

Start date: October 2008
Phase: N/A
Study type: Interventional

We will compare three study groups receiving metoprolol, esmolol, or placebo. Level of anesthesia will be titrated to achieve the same range of BIS value in all groups. Our hypothesis is that the metoprolol and esmolol groups will require a lower level of anesthetic agent to achieve the targeted BIS range, compared to the placebo group. Our objective is to clarify if metoprolol, in a dose range used for perioperative cardiac protection, decreases anesthetic requirement.

NCT ID: NCT00755443 Completed - Clinical trials for Coronary Artery Disease

Sirolimus-Eluting Stent Versus Standard Stent in Diabetic

DIABETES
Start date: February 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study was to determine whether Sirolimus stent implantation is effective in reducing neointimal hyperplasia as compared to Bare metal stent in diabetic patients with de novo coronary artery stenosis.

NCT ID: NCT00754975 Completed - Clinical trials for Coronary Artery Disease

JACTAX LD Drug Eluting Stent Trial

Start date: January 2008
Phase: N/A
Study type: Interventional

Prospective, multi-center, randomized trial. A maximum of 130 patients will be enrolled, in a 2:1 ratio to receive either the JACTAX LD stent or the TAXUS™ Libertè™ stent to evaluate the efficacy of the product.

NCT ID: NCT00754728 Completed - Clinical trials for Coronary Artery Disease

"JACTAX" Trial Drug Eluting Stent Trial

Start date: July 2007
Phase: N/A
Study type: Interventional

Prospective, multi-center, non-randomized registry. 100 patients will be enrolled at up to 10 clinical sites in Europe. The results of this study will be compared to the TAXUS™ ATLAS clinical trial to evaluate the safety of the product.

NCT ID: NCT00754533 Completed - Clinical trials for Acute Coronary Syndrome

Continuous Versus Interval Training in Patients With Coronary Artery Disease: FRAXIO Study

FRAXIO
Start date: September 2008
Phase: N/A
Study type: Interventional

The benefits of cardiac rehabilitation have been clearly demonstrated. In particular exercise training is recognized to be part of modern management after coronary artery disease. However methods of prescribing exercise-training programs and the exercise intensity are difficult to determine. The objective of this randomised clinical trial is to determine whether appropriate endurance exercise training improves the ventilatory threshold, the exercise tolerance and the quality of life in patients with coronary artery disease. Patients are randomized to continuous training or aerobic interval training respectively: 80%-versus maximal-workload at the ventilatory threshold. For each patient, the intensity of exercise training is determined by a first exercise test with gas analysis using parameters of sub maximal exercise capacity such as ventilatory threshold. Others parameters of functional capacity are also considered. Duration of the rehabilitation stage is between 7 to 10 weeks. Dyspnoea assessment at maximal intensity, quality of life measurement by SF36, drugs and events are reported. Maximal exercise tests with gas exchange measurements are performed after training program and at 6 months follow-up to compare the different cardio respiratory parameters in the two groups before and after exercise training and to evaluate the more effective endurance training program.

NCT ID: NCT00753935 Completed - Clinical trials for Coronary Artery Disease

Aspirin Resistance in Coronary Artery Disease

Start date: June 2006
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to evaluate possible mechanisms of aspirin resistance at a molecular level in aspirin-treated patients with coronary artery disease. We hypothesize that certain patient characteristics associate with aspirin resistance. In addition, we will compare the effects of enteric-coated aspirin and chewable aspirin.

NCT ID: NCT00752752 Completed - Myocardial Ischemia Clinical Trials

The Acute Cardiovascular Effects of Marathon Running Using Magnetic Resonance Imaging

MARATHON-MRI
Start date: September 2008
Phase: N/A
Study type: Observational

Using blood testing and cardiac magnetic resonance imaging (MRI), the investigators aim to determine if there are necrotic areas of myocardium in participants who complete a marathon. In addition, the investigators aim to describe the acute and chronic structural abnormalities that occur as a result of endurance training. The study hypothesis is that myocardial necrosis is present in runners completing a marathon competition.